Search results for "Keeping tabs"
Spotlight on resistance training
Several recent studies found modest benefits to patients with type 1 or type 2 diabetes participating in strengthening exercises.
https://diabetes.acponline.org/archives/2022/12/09/5.htm
9 Dec 2022
Spotlight on weekly insulins
Pharmaceutical manufacturers recently published studies on investigational basal insulin formulations that could be taken once a week by patients with type 1 or type 2 diabetes.
https://diabetes.acponline.org/archives/2023/05/12/5.htm
12 May 2023
Spotlight on statins in diabetes
Recent studies looked at how statins negatively affect glycemic control but improve cardiovascular mortality, as well as the reasons patients with diabetes don't receive prescriptions for statins despite recommendations.
https://diabetes.acponline.org/archives/2023/04/14/5.htm
14 Apr 2023
Spotlight on prescribing patterns
One study found that physicians were unlikely to deprescribe hypoglycemia-causing medications in older diabetes patients, while others found suboptimal use of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors, and additional recommended medications.
https://diabetes.acponline.org/archives/2023/03/10/5.htm
10 Mar 2023
Spotlight on diabetes incidence in the pandemic
Two studies tried to determine whether COVID-19 infection leads to a subsequent increase in the risk of developing diabetes, while another highlighted how type 2 diabetes has risen among youth since the start of the pandemic.
https://diabetes.acponline.org/archives/2023/02/10/5.htm
10 Feb 2023
Spotlight on diabetes and chronic kidney disease
A study showed that chronic kidney disease has declined among U.S. adults with diabetes. A meta-analysis found that sodium-glucose cotransporter-2 inhibitors prevented kidney decline similarly in those with and without diabetes. A survey identified knowledge gaps among prescribers on this topic.
https://diabetes.acponline.org/archives/2022/11/11/5.htm
11 Nov 2022
Spotlight on diabetes drug class comparisons
A large trial compared insulin, a sulfonylurea, a glucagon-like peptide-1 (GLP-1) receptor agonist, and a dipeptidyl peptidase-4 inhibitor as second-line therapy, while a modeling study considered GLP-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors as first-line agents.
https://diabetes.acponline.org/archives/2022/10/14/5.htm
14 Oct 2022
Spotlight on innovative uses of CGM
Recent trials indicated effectiveness of open-source automated insulin delivery systems, inpatient insulin management based on continuous glucose monitoring (CGM), and CGM for certain patients with type 2 diabetes who are not taking insulin.
https://diabetes.acponline.org/archives/2022/09/16/5.htm
16 Sep 2022
Spotlight on older diabetes patients
Recent studies of older patients with diabetes described the effectiveness of a lifestyle intervention, low use of continuous glucose monitoring, and high risk of falls with hypoglycemia.
https://diabetes.acponline.org/archives/2022/08/12/5.htm
12 Aug 2022
Spotlight on COVID-19 and diabetes
Experts gave advice on which diabetes drugs should be stopped in patients with COVID-19, and studies highlighted associations between the two diseases.
https://diabetes.acponline.org/archives/2020/05/08/5.htm
8 May 2020